CD161 receptor participates in both impairing NK cell cytotoxicity and the response to glycans and vimentin in patients with rheumatoid arthritis

RICHTER, J., BENSON, V., GROBÁROVÁ, V., SVOBODA, J., VENCOVSKÝ, J., SVOBODOVÁ, R., FIŠEROVÁ, A. CD161 receptor participates in both impairing NK cell cytotoxicity and the response to glycans and vimentin in patients with rheumatoid arthritis. Clinical Immunology. 2010, 136(1), 139-147. ISSN 1521-6616. E-ISSN 1521-7035. Available: doi: 10.1016/j.clim.2010.03.005